Does androgen-deprivation therapy for prostate cancer increase the risk for thromboembolic disease?

被引：0
|
作者：
Pinthus, Jehonathan H. [1 ]
Duivenvoorden, Wilhelmina C. [1 ]
机构：
[1] McMaster Univ, Div Urol, Dept Surg, Hamilton, ON, Canada
来源：
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2017年 / 11卷 / 1-2期
关键词：
VENOUS THROMBOEMBOLISM;
D O I：
10.5489/cuaj.4394
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：39 / 40
页数：2
相关论文
共 50 条
  • [21] Does Use of Androgen Deprivation Therapy (ADT) in Men with Prostate Cancer Increase the Risk of Sarcopenia?
    Patrick J. Owen
    Robin M. Daly
    Jack Dalla Via
    Niamh L. Mundell
    Patricia M. Livingston
    Timo Rantalainen
    Steve F. Fraser
    Calcified Tissue International, 2019, 105 : 403 - 411
  • [22] Re: Does Comorbidity Influence the Risk of Myocardial Infarction or Diabetes During Androgen-Deprivation Therapy for Prostate Cancer?
    Griebling, Tomas L.
    JOURNAL OF UROLOGY, 2014, 191 (06): : 1784 - 1785
  • [23] Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
    Smith, Matthew R.
    Egerdie, Blair
    Toriz, Narciso Hernandez
    Feldman, Robert
    Tammela, Teuvo L. J.
    Saad, Fred
    Heracek, Jiri
    Szwedowski, Maciej
    Ke, Chunlei
    Kupic, Amy
    Leder, Benjamin Z.
    Goessl, Carsten
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (08): : 745 - 755
  • [24] Metabolic and cardiovascular risks of androgen-deprivation therapy for prostate cancer
    Nambudiri, Vinod E.
    Keating, Nancy L.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (04) : 531 - 537
  • [25] Reimbursement Policy and Androgen-Deprivation Therapy for Prostate Cancer.
    Shahinian, Vahakn B.
    Kuo, Yong-Fang
    Gilbert, Scott M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (19): : 1822 - 1832
  • [26] Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer
    Shore, Neal D.
    Saad, Fred
    Cookson, Michael S.
    George, Daniel J.
    Saltzstein, Daniel R.
    Tutrone, Ronald
    Akaza, Hideyuki
    Bossi, Alberto
    van Veenhuyzen, David F.
    Selby, Bryan
    Fan, Xiaolin
    Kang, Vicky
    Walling, Jackie
    Tombal, Bertrand
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (23): : 2187 - 2196
  • [27] Cardiovascular and Metabolic Effects of Androgen-Deprivation Therapy for Prostate Cancer
    Gupta, Dipti
    Chuy, Katherine Lee
    Yang, Ji Can
    Bates, Megan
    Lombardo, Marissa
    Steingart, Richard M.
    JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (10) : 580 - +
  • [28] Reimbursement Policy and Androgen-Deprivation Therapy for Prostate Cancer REPLY
    Shahinian, Vahakn B.
    Kuo, Yong-Fang
    Gilbert, Scott M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06): : 580 - 580
  • [29] Androgen-Deprivation Therapy and Metabolic Syndrome in Men With Prostate Cancer
    Harrington, Joanne M.
    Schwenke, Dawn C.
    Epstein, Dana R.
    Bailey, Donald E., Jr.
    ONCOLOGY NURSING FORUM, 2014, 41 (01) : 21 - 29
  • [30] Does androgen deprivation therapy in men with prostate cancer increase cardiovascular morbidity?
    Steven M Corsello
    Philip W Kantoff
    Nature Clinical Practice Urology, 2008, 5 : 80 - 81
12345